Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition has informed BSE that the trading window for its securities will be closed from October 1, 2025 until 48 hours after the company's financial results for the quarter ending September 30, 2025 (Q2 FY26) are made public. This is filed pursuant to SEBI's Prohibition of Insider Trading Regulations, 2015 (Schedule B, Clause 4). The intimation is signed by Managing Director Mathurakavi Srinivasa Raghavan Ayyangar. This is a routine compliance measure taken by companies ahead of quarterly results to prevent insider trading.
No direct impact on retail shareholders. This signals that Q2 FY26 results are expected to be announced in the coming weeks and that insiders (directors, KMPs, connected persons) are barred from trading during this period.